Clinical Trials in Shandong, Jinan
3 recruiting
Showing 1–3 of 3 trials
Recruiting
Phase 1
Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacokinetics, and Preliminary Efficacy of FS-8002
Advanced Solid Tumors
Shanghai Pushi Medical Science Co. Ltd66 enrolled10 locationsNCT06832982
Recruiting
Phase 3
Firmonertinib Versus Platinum Based Chemotherapy as First-line Treatment for NSCLC With EGFR PACC or EGFR l861q Mutation
NSCLC (Advanced Non-small Cell Lung Cancer)EGFR
Allist Pharmaceuticals, Inc.300 enrolled2 locationsNCT06956001
Recruiting
Phase 1
An Open-label, Multi-center, Dose-escalation and Cohort Expansion Phase I/IIa Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetic Profile and Efficacy of ACR246 in Patients With Advanced Solid Tumors
Advanced Solid Tumors
Hangzhou Adcoris Biopharmacy Co., Ltd77 enrolled6 locationsNCT06238401